More than 2,000 professionals in psychiatry and mental health met in Oviedo in the most important annual event from the Iberian Peninsula.

-Congress have assisted the leaders of the societies of global, European, Latin American and Spanish Psychiatry

– the main themes of the Congress among the novelties of the international classification of diseases (ICD-11), the status of neuropsychiatric Europe diseases, progress in these diseases early diagnosis and the impact of the limitation period for active treatment people with mental illness

– were they discussed developments in the field of genetics and innovations in aspects relating to addictions, gender-based violence, in addition, impact on mental health child abuse, suicide, disorders of eating and sleeping, etc

– also have been highlighted recent advances in psychiatric treatmentboth pharmacological with the emergence of new drugs this year, as brain stimulation and psychotherapy

Oviedo, November 2011- Tuesday 8th began in the Palacio de Exposiciones y Congresos of Oviedo the 15th National Congress of Psychiatry, the most important mental health of Latin America scientific event and focuses on the capital the Principality to the most outstanding representatives of world psychiatry.

Thus, organized by the Spanish society of Psychiatry (SEP), the Spanish society of Biological Psychiatry (SEPB) and the Spanish Foundation of Psychiatry and Mental Health (FEPSM), the event welcomed over two thousand professionals in mental health, both Spanish and foreign, in addition to the assistance of the leaders of the World Psychiatric Association (WPA), the European Association of Psychiatry (EPA) and the Psychiatric Association of Latin America (APAL).

As has been pointed out at the opening of the Congress Professor Julio Bobes, President of the Organizing Committee and the SEPB, and Professor of Psychiatry of the University of Oviedo, among the main topics that will be addressed at the Congress, include the presentation of the manifesto of Oviedo against stigma in Mental healthNews from the international classification of diseases (ICD-11), the State of neuropsychiatric diseases in Europe and advances in early diagnosis of these diseases, the developments in the field of genetics.

Also be talked about addictions, gender-based violence, impact on children’s mental health from abuse, suicide, disorders of eating and sleeping, etc.

Also, the entry into force of the new regulation on active ingredient influences our requirements and it can cause problems with adherence to the treatment of persons with serious mental illness. This type of people with this diagnosis presented major problems because of their pathology to maintain their adherence to treatment; to prescribe by active ingredient, the name and presentation of the medicinal product may change several times, but the active principle is the same; This can lead to confusion for the patient and, therefore, to stop the treatment, the serious consequences that this neglect can be harnessed together ”.

They have also been highlighted recent advances in psychiatric treatment, both pharmacological with the emergence of new drugs on the market aimed at patients with a diagnosis of bipolar illness, depression and psychosis, such as in brain stimulation therapy and psychotherapy. Also addressed the uneven application of the law of unit in the different autonomous communities ”.

Mass participation

Bobes has highlighted the massive participation of professionals in the Spanish mental health in this quote in which we have selected a total of 618 communications in the form of poster, will be held 15 formal symposia, 5 satellite symposia, 15 workshops, 4 plenary sessions, 3 forums for discussion, 8 courses8 symposiums of scientific societies and the introduction of 4 new books on psychiatry ”.

For its part, the Spanish society of Biological Psychiatry (SEPB) awarded II Prize to emerging researchers, the sixth Prize to young researchers accredited, the VI reference researchers award, III Prize to the researcher of the year, III Prize lifetime achievement in research, the award for the best Doctoral thesis course 2009-2010 and the 16th Award “Amadeus Sánchez Blanqué” on researchón clinic in psychiatry.

Finally, the European College of American (ECNP) presented his II award to the best posters in Neuropsicofarmacología.